Amplitude (NASDAQ:AMPL – Get Free Report) had its target price lifted by equities researchers at UBS Group from $10.00 to $13.00 in a research report issued on Thursday,Benzinga reports. The brokerage ...

Combining bright-field and edge-enhanced imaging affords an effective avenue for extracting complex morphological information ...

Shares of Amplitude, Inc. (NASDAQ:AMPL – Get Free Report) hit a new 52-week high on Thursday after Morgan Stanley raised their price target on the stock from $11.00 to $13.00. Morgan Stanley currently ...

Fintel reports that on February 20, 2025, Baird upgraded their outlook for Amplitude (NasdaqCM:AMPL) from Neutral to ...

Shares of data analytics software provider Amplitude (NASDAQ:AMPL) jumped 22.7% in the pre-market session after the company ...

Fintel reports that on February 20, 2025, DA Davidson upgraded their outlook for Amplitude (NasdaqCM:AMPL) from Neutral to ...

Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its consolidated sales for the first ...

Piper Sandler raised the firm’s price target on Amplitude (AMPL) to $17 from $15 and keeps an Overweight rating on the shares. The firm cites ...

Hello, everyone. Welcome to Amplitude's Fourth Quarter and Full Year 2024 Earnings Call. I'm John Streppa, Head of Investor Relations. Joining me today are Spenser Skates, CEO and Co-Founder of ...

Toll Brothers’ targeted customers are wealthier, have stronger credit profiles, and are more likely to make all-cash payments than the typical homebuyer. As such, interest rates are less of a factor ...

Reverb Therapeutics, a leader in harnessing the natural immune system and cytokine signaling to treat life-threatening diseases, announced it has closed a USD $12 Million financing led by founding ...